AIIMS team inspects Kota hospitals to probe maternal death cases

IMT News Desk
IMT News Desk
· 2 min read
AIIMS team inspects Kota’s New Medical College and J.K. Lon Government Hospital to probe recent maternal deaths and post‑C‑section complications

A high‑level team from the All India Institute of Medical Sciences (AIIMS), comprising specialists from AIIMS Delhi and AIIMS Jodhpur, conducted a detailed inspection of Kota’s New Medical College Hospital and J.K. Lon Government Hospital on Saturday to probe a cluster of recent maternal deaths and critical post‑delivery complications.

Scope of the inspection

The seven‑member expert panel spent nearly six hours touring operating theatres, labour rooms, intensive care units (ICUs), emergency wards, nephrology units, pharmacies, and record rooms at both facilities. The focus was on infection‑control measures, surgical protocols, bedside management of post‑partum women, and documentation of adverse events following Caesarean deliveries.

Deaths and complications

The inspection follows the deaths of four women in the past week due to severe complications after Caesarean sections, along with several others suffering kidney failure and systemic infections. Families have alleged lapses in sterilization, use of contaminated injections or substandard consumables, delayed treatment, and inadequate monitoring, though the official cause remains under investigation.

Government response and SOP overhaul

The Rajasthan government has ordered a high‑level mortality audit for mothers and newborns at JK Lon Hospital and tightened adherence to infection‑control and C‑section protocols in operating theatres and ICUs across Kota and Bundi districts. The AIIMS team is expected to submit its findings and recommendations to the Union Health Ministry within the next two to three days, after which new Standard Operating Procedures (SOPs) and potential administrative actions are likely to follow.

Public and political reaction

The cluster of maternal deaths has triggered strong public outcry and political attention, with Lok Sabha Speaker Om Birla flagging the matter as “extremely sensitive” and demanding strict accountability. The state has also suspended 24 medicines and devices across public hospitals pending quality testing, amplifying concerns about supply‑chain and quality‑assurance lapses in the public health system.

What the probe aims to clarify

Key questions before the expert panel include whether the infections stemmed from contaminated consumables, lapses in OT sterilization, delays in initiating antibiotics or renal support, or weak adherence to existing obstetric protocols. Policy watchers say the Kota episode is likely to drive a broader review of maternal‑care standards and surveillance mechanisms in tertiary‑level government hospitals across Rajasthan and other states.

Read Next

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care
News
July 17, 2026

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care

Menthra, an AI-powered emotional wellbeing platform, today announced the launch of Menthra Care in India, expanding its platform to connect users with verified therapists, coaches, licensed clinical professionals and care organisations when they need support beyond an AI companion. The launch follows Menthra’s India debut in June, which saw tens of thousands of users join […]
Article by: IMT News Desk
IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care
News
July 17, 2026

IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care

Against a backdrop of geopolitical uncertainty, supply chain disruptions and rapid advances in artificial intelligence (AI) and precision medicine, FutureHealth.Now provided a platform for industry leaders to explore how innovation, technology and new models of care can help tackle rising healthcare costs, workforce pressures and growing demand for services across the region. At his opening […]
Article by: IMT News Desk
Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill
News
July 16, 2026

Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill

Novo Nordisk has secured European Commission approval for its once-daily Wegovy pill, giving the Danish drugmaker a major boost in the fast-growing obesity-treatment market. The approval makes it the first oral GLP-1 weight-loss treatment cleared in the European Union for adults with obesity or overweight who also have at least one weight-related health condition. The […]
Article by: IMT News Desk
Sun Pharma Wins South Africa Approval to Launch Generic Ozempic
News
July 16, 2026

Sun Pharma Wins South Africa Approval to Launch Generic Ozempic

India’s Sun Pharmaceutical Industries has received approval from South Africa’s health regulator to manufacture and sell a generic version of semaglutide, the active ingredient in Novo Nordisk’s Ozempic and Wegovy, expanding its presence in the fast-growing GLP-1 market. The South African Health Products Regulatory Authority’s clearance allows Sun Pharma to market the injectable treatment for […]
Article by: IMT News Desk